148 related articles for article (PubMed ID: 12652245)
1. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.
Alldredge CD; Garretson BR
Retina; 2003 Feb; 23(1):113-6. PubMed ID: 12652245
[No Abstract] [Full Text] [Related]
2. Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis.
Martinez JA
Arch Ophthalmol; 2003 Nov; 121(11):1658-9. PubMed ID: 14609935
[No Abstract] [Full Text] [Related]
3. Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis.
Li KK; Goh TY; Parsons H; Chan WM; Lam DS
Clin Exp Ophthalmol; 2005 Oct; 33(5):542-4. PubMed ID: 16181291
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.
Smithen LM; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):884-5. PubMed ID: 15531339
[TBL] [Abstract][Full Text] [Related]
5. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
Wu L; Evans T; Arévalo JF; Berrocal MH; Rodríguez FJ; Hsu M; Sánchez JG
Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037
[TBL] [Abstract][Full Text] [Related]
6. [Intravitreal triamcinolone injection in the treatment of idiopathic juxtafoveal telangiectasis].
Maia OO; Takahashi WY; Bonanomi MT; Nascimento VP; Melo CS
Arq Bras Oftalmol; 2006; 69(6):941-4. PubMed ID: 17273694
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis.
Vianna RN; Squeri G; Turquetti R; Brasil OF; Burnier MN
Can J Ophthalmol; 2008 Aug; 43(4):492-3. PubMed ID: 18711476
[No Abstract] [Full Text] [Related]
8. Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.
Kotoula MG; Chatzoulis DZ; Karabatsas CH; Tsiloulis A; Tsironi EE
Ophthalmic Surg Lasers Imaging; 2009; 40(1):65-7. PubMed ID: 19205501
[TBL] [Abstract][Full Text] [Related]
9. Juxtafoveal telangiectasias.
Querques G; Delle Noci N
Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
[No Abstract] [Full Text] [Related]
10. Intravitreous ranibizumab as treatment for macular telangiectasia type 2.
Lira RP; Silva VB; Cavalcanti TM; de Souza AC; Pinto AP
Arch Ophthalmol; 2010 Aug; 128(8):1075-8. PubMed ID: 20697014
[No Abstract] [Full Text] [Related]
11. [Treatment of idiopathic juxtafoveolar retinal telangiectasis with bevacizumab (avastin)].
Schulze S; Mennel S
Klin Monbl Augenheilkd; 2007 Oct; 224(10):787-90. PubMed ID: 17952823
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of idiopathic juxtafoveal telangiectasis in Koreans.
Lee SW; Kim SM; Kim YT; Kang SW
Korean J Ophthalmol; 2011 Aug; 25(4):225-30. PubMed ID: 21860567
[TBL] [Abstract][Full Text] [Related]
13. Re: Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis.
Querques G; Delle Noci N
Retina; 2008 Feb; 28(2):368-9; author reply 369-70. PubMed ID: 18301049
[No Abstract] [Full Text] [Related]
14. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
15. Idiopathic juxtafoveal telangiectasis in association with celiac sprue.
Lee HC; Liu M; Ho AC
Arch Ophthalmol; 2004 Mar; 122(3):411-3. PubMed ID: 15006867
[No Abstract] [Full Text] [Related]
16. Bilateral retinal vasculopathy in a patient with dyskeratosis congenita.
Teixeira LF; Shields CL; Marr B; Horgan N; Shields JA
Arch Ophthalmol; 2008 Jan; 126(1):134-5. PubMed ID: 18195234
[No Abstract] [Full Text] [Related]
17. Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
Arevalo JF; Sanchez JG; Garcia RA; Wu L; Berrocal MH; Rodriguez FJ; Rodríguez A; Novoa LA; Garcia-Amaris R
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1673-80. PubMed ID: 17619895
[TBL] [Abstract][Full Text] [Related]
18. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
Charbel Issa P; Holz FG; Scholl HP
Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
[TBL] [Abstract][Full Text] [Related]
19. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Rishi P; Rishi E; Shroff D
Indian J Ophthalmol; 2009; 57(3):241-2. PubMed ID: 19384026
[No Abstract] [Full Text] [Related]
20. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Er H
Am J Ophthalmol; 2006 Oct; 142(4):710; author reply 710. PubMed ID: 17011888
[No Abstract] [Full Text] [Related]
[Next] [New Search]
